The intraperitoneal injection of hASCs-exo in PD animals model reduces the aggregation of α-SYN, increases the number of tyrosine hydroxylase (TH)-expressing positive cells, and improves dopamine production compared to the MPTP group without exosome treatment. The gene discussed is TH; the disease is Parkinson disease.